Cerenome, Inc.
CNSY- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001095981
No open-market purchases or sales by Cerenome, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.89M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Cerenome, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 24 | 23 | −1 |
| Shares | 1.93M | 3.26M | +1.33M (+69.0%) |
| Value | $2.03M | $3.26M | +$1.23M (+60.8%) |
New holders (3)
Institutions that held Cerenome, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Parkman Healthcare Partners LLC | 1,526,316 | $1.53M | 0.45% |
| Otter Creek Advisors, LLC | 83,901 | $84.0K | 0.07% |
| Barclays PLC | 1 | $0 | 0.00% |
Sold out (4)
Institutions that held Cerenome, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Two Sigma Investments, LP | 98,628 | $104.0K |
| Citadel Advisors LLC | 83,149 | $87.0K |
| Dimensional Fund Advisors LP | 25,507 | $27.0K |
| Two Sigma Securities, LLC | 13,989 | $15.0K |